on Relief Therapeutics Holdings AG (NASDAQ:RLFTF)
Relief Therapeutics Releases Annual Report and Shares Corporate Update
Relief Therapeutics Holding SA announced the release of its Annual Report for the year 2023 today. The report is now accessible on the company's website. Michelle Lock, the interim chief executive officer at Relief, highlighted the company's intensified focus on rare diseases and its strategic business realignment. She expressed excitement over the ongoing development of RLF-TD011 and RLF-OD032, aimed at treating epidermolysis bullosa and phenylketonuria, respectively.
R. H.Copyright © 2024 FinanzWire, all reproduction and representation rights reserved. Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Relief Therapeutics Holdings AG news